Ken B Waites Selected Research

Ken B Waites Research Topics

Disease

27	Infections 01/2022 - 08/2002
9	Pneumonia (Pneumonitis) 01/2022 - 08/2002
4	Bacterial Pneumonia 01/2022 - 01/2017
3	Respiratory Tract Infections (Respiratory Tract Infection) 01/2019 - 08/2009
3	Body Weight (Weight, Body) 01/2015 - 09/2011
3	Ureaplasma Infections (Ureaplasma Infection) 04/2014 - 09/2011
2	Inflammation (Inflammations) 11/2016 - 01/2006
2	Bronchopulmonary Dysplasia 05/2013 - 09/2011
2	Chorioamnionitis 12/2012 - 05/2011
2	Bacteriuria 01/2006 - 01/2004
1	Coinfection 01/2022
1	Confusion (Bewilderment) 12/2021
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2019
1	Bacterial Infections (Bacterial Infection) 01/2019
1	Pharyngitis (Sore Throat) 01/2018
1	Hyperammonemia 02/2017
1	Peritonitis 01/2015
1	Persistent Infection 04/2014
1	Premature Birth (Birth, Premature) 12/2012
1	Lung Injury 12/2012
1	Lemierre Syndrome 12/2010
1	Osteomyelitis 09/2010
1	Wounds and Injuries (Trauma) 09/2010
1	Open Fractures (Compound Fracture) 09/2010
1	Encephalitis (Encephalitis, Rasmussen) 08/2009
1	Asthma (Bronchial Asthma) 12/2008
1	Chronic Disease (Chronic Diseases) 12/2008
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2008
1	Neurogenic Urinary Bladder (Bladder, Neurogenic) 01/2006
1	Gram-Negative Bacterial Infections 01/2005
1	Pyuria 01/2004

Drug/Important Bio-Agent (IBA)

10	MacrolidesIBA 10/2020 - 10/2004
9	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 09/2010
7	Azithromycin (Zithromax)FDA LinkGeneric 10/2019 - 09/2011
5	FluoroquinolonesIBA 10/2019 - 10/2004
3	Pharmaceutical PreparationsIBA 01/2022 - 01/2005
3	lefamulinIBA 01/2022 - 12/2021
2	PleuromutilinsIBA 01/2022 - 12/2021
2	Moxifloxacin (Avelox)FDA Link 01/2022 - 12/2021
2	23S Ribosomal RNAIBA 10/2019 - 08/2009
2	Anti-Infective Agents (Microbicides)IBA 02/2017 - 08/2002
1	Urea (Carbamide)FDA LinkGeneric 12/2021
1	NitrogenIBA 12/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Nucleic AcidsIBA 01/2020
1	QuinolonesIBA 01/2019
1	AllergensIBA 01/2019
1	Immunoglobulin E (IgE)IBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	Minocycline (Cyclops)FDA LinkGeneric 01/2019
1	antineoplaston A10 (A 10)IBA 01/2018
1	gepotidacinIBA 10/2017
1	PristinamycinIBA 01/2017
1	TP-271IBA 01/2017
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2017
1	SuspensionsIBA 01/2017
1	LactamsIBA 01/2017
1	ConnexinsIBA 11/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2016
1	Connexin 43 (Connexin43)IBA 11/2016
1	Adenosine Monophosphate (AMP)IBA 04/2014
1	Antimicrobial PeptidesIBA 04/2014
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 12/2012
1	Virulence Factors (Pathogenicity Factors)IBA 05/2012
1	Biological ProductsIBA 09/2011
1	Interleukin-6 (Interleukin 6)IBA 05/2011
1	Gentamicins (Gentamicin)FDA LinkGeneric 09/2010
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 09/2010
1	7- (7- amino- 7- methyl- 5- azaspiro(2.4)heptan- 5- yl)- 6- fluoro- 1- (2- fluoro- 1- cyclopropyl)- 1,4- dihydro- 8- methoxy- 4- oxo- 3- quinolinecarboxylic acidIBA 10/2008
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 01/2008
1	Streptogramin BIBA 07/2006
1	Acetic Acid (Vinegar)FDA LinkGeneric 01/2006
1	SolutionsIBA 01/2006
1	Neomycin FDA LinkGeneric 01/2006
1	Polymyxins (Polymyxin)IBA 01/2006
1	TetracyclinesIBA 10/2004
1	Capsules (Microcapsules)IBA 01/2004
1	delafloxacinIBA 12/2003
1	cethromycinIBA 01/2003
1	garenoxacinIBA 01/2003
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 08/2002
1	Ertapenem (Invanz)FDA Link 08/2002

Therapy/Procedure

5	Therapeutics 12/2021 - 07/2006
1	Transplantation 10/2020
1	Donor Selection 02/2017
1	Peritoneal Dialysis 01/2015
1	Punctures 01/2015
1	Indwelling Catheters (Indwelling Catheter) 01/2006